Cboe Global Markets, Inc.
Cboe Global Markets, Inc. (CBOE) Financial Performance & Income Statement Overview
Review Cboe Global Markets, Inc. (CBOE) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Cboe Global Markets, Inc. (CBOE) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Cboe Global Markets, Inc. CBOE financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $1.20B | $1.11B | $1.06B | $974.00M |
Cost of Revenue | $62.30M | $695.00M | $642.80M | $492.00M |
Gross Profit | $1.13B | $412.60M | $412.90M | $482.00M |
Gross Profit Ratio | $0.95 | $0.37 | $0.39 | $0.49 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $20.80M | $153.90M | $34.50M | $151.20M |
Operating Expenses | $149.00M | $114.10M | $105.50M | $222.10M |
Total Costs & Expenses | $211.30M | $809.10M | $748.30M | $682.30M |
Interest Income | $8.40M | $7.20M | $11.40M | $4.60M |
Interest Expense | $12.80M | $12.90M | $12.80M | $12.80M |
Depreciation & Amortization | $30.30M | $32.10M | $31.80M | $31.80M |
EBITDA | $393.30M | $330.70M | $353.60M | $323.50M |
EBITDA Ratio | $0.33 | $0.30 | $0.33 | $0.33 |
Operating Income | $353.90M | $298.50M | $307.40M | $291.70M |
Operating Income Ratio | $0.30 | $0.27 | $0.29 | $0.30 |
Other Income/Expenses (Net) | -$3.70M | -$18.80M | $1.60M | -$7.10M |
Income Before Tax | $350.20M | $279.70M | $309.00M | $203.00M |
Income Before Tax Ratio | $0.29 | $0.25 | $0.29 | $0.21 |
Income Tax Expense | $99.60M | $83.20M | $90.50M | $62.60M |
Net Income | $250.60M | $196.50M | $217.40M | $140.40M |
Net Income Ratio | $0.21 | $0.18 | $0.21 | $0.14 |
EPS | $2.38 | $1.87 | $2.08 | $1.33 |
Diluted EPS | $2.37 | $1.86 | $2.07 | $1.33 |
Weighted Avg Shares Outstanding | $104.70M | $104.80M | $104.70M | $105.90M |
Weighted Avg Shares Outstanding (Diluted) | $105.10M | $105.10M | $105.10M | $105.90M |
Financial performance has remained strong, with revenue growing from $974.00M in Q2 2024 to $1.20B in Q1 2025. Gross profit continued to perform well, with margins at 95% in the latest quarter. Operating income reached $353.90M in Q1 2025, holding a steady 30% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $393.30M. Net income rose to $250.60M, keeping EPS at $2.38. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan